This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
ESAL.Y Overzicht aandelen
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 1/6 |
| Toekomstige groei | 4/6 |
| Prestaties in het verleden | 1/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 3/6 |
Eisai Co., Ltd. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | JP¥61.51 |
| 52 Week Hoogtepunt | JP¥73.90 |
| 52 Week Laag | JP¥36.88 |
| Bèta | 0.21 |
| 11 maand verandering | -7.24% |
| 3 maanden verandering | 2.28% |
| 1 Jaar Verandering | 19.69% |
| 33 jaar verandering | -28.69% |
| 5 jaar verandering | 9.25% |
| Verandering sinds IPO | 208.81% |
Recent nieuws en updates
Recent updates
Rendement voor aandeelhouders
| ESAL.Y | US Pharmaceuticals | US Markt | |
|---|---|---|---|
| 7D | -4.4% | -1.7% | -0.9% |
| 1Y | 19.7% | 23.5% | 38.9% |
Rendement versus industrie: ESAL.Y exceeded the US Pharmaceuticals industry which returned 3.2% over the past year.
Rendement versus markt: ESAL.Y exceeded the US Market which returned -12.5% over the past year.
Prijsvolatiliteit
| ESAL.Y volatility | |
|---|---|
| ESAL.Y Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 9.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stabiele aandelenkoers: ESAL.Y has not had significant price volatility in the past 3 months.
Volatiliteit in de loop van de tijd: ESAL.Y's weekly volatility (6%) has been stable over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1941 | 11,322 | Haruo Naito | www.eisai.co.jp |
Eisai Co., Ltd. Samenvatting
| ESAL.Y fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$17.66b |
| Inkomsten(TTM) | US$247.68m |
| Inkomsten(TTM) | US$5.78b |
71.3x
Koers/Winstverhouding3.1x
P/S-verhoudingIs ESAL.Y overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| ESAL.Y resultatenrekening (TTM) | |
|---|---|
| Inkomsten | JP¥752.50b |
| Kosten van inkomsten | JP¥187.50b |
| Brutowinst | JP¥565.00b |
| Overige uitgaven | JP¥532.77b |
| Inkomsten | JP¥32.23b |
Laatst gerapporteerde inkomsten
Sep 30, 2022
Volgende inkomensdatum
Feb 06, 2023
| Winst per aandeel (EPS) | 112.35 |
| Brutomarge | 75.08% |
| Nettowinstmarge | 4.28% |
| Schuld/Eigen Vermogen Verhouding | 11.2% |
Hoe presteerde ESAL.Y op de lange termijn?
Bekijk historische prestaties en vergelijking